AK Medical Holdings Limited (HKG:1789)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.870
+0.040 (0.83%)
Sep 30, 2026, 4:08 PM HKT

AK Medical Holdings Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, AK Medical Holdings stock has a consensus rating of "Strong Buy" and an average price target of $7.82. The average 1-year stock price forecast is 60.57% higher than the current stock price, while the lowest is $7.01 (+43.94%) and the highest is $8.44 (+73.31%).

Price Target: $7.82 (+60.57%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.01$7.82$7.75$8.44
Change+43.94%+60.57%+59.14%+73.31%
* Price targets were last updated on Sep 1, 2026.

Analyst Ratings

The average analyst rating for AK Medical Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26Jul '26Aug '26Sep '26
Strong Buy456666
Buy000000
Hold110000
Sell000000
Strong Sell000000
Total566666

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$36.40
BuyMaintains$36.40+647.43%Sep 1, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$7.63
BuyMaintains$7.63+56.67%Aug 29, 2026
Goldman Sachs
Goldman Sachs
Buy
Maintains
$7.60
BuyMaintains$7.60+56.06%Aug 27, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.65B
from 1.48B
Increased by 11.06%
Revenue Next Year
1.83B
from 1.65B
Increased by 10.86%
EPS This Year
0.37
from 0.30
Increased by 22.11%
EPS Next Year
0.42
from 0.37
Increased by 12.84%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
761.44M1.05B1.09B1.35B1.48B1.65B
Revenue Growth
-26.46%38.17%3.98%23.09%10.11%11.06%
Gross Profit
499.19M636.44M674.49M808.19M897.40M1.03B
Gross Margin
65.56%60.49%61.66%60.03%60.54%62.60%
Operating Income
99.44M238.34M211.48M300.78M373.88M462.21M
Net Income
92.62M204.77M182.10M273.93M339.09M411.90M
EPS
----0.300.37
EPS Growth
----26.25%22.11%
Forward PE
32.4737.2320.9815.7715.2211.25
Dividend / Share
0.020.050.040.070.110.10
Dividend Growth
-39.53%160.59%-23.04%65.64%56.73%-8.83%
Free Cash Flow
----272.00M465.00M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High1.7B
Avg1.6B
Low1.6B

Revenue Growth

Revenue Growth202620272028
High
12.1%
Avg
11.1%
Low
9.9%

EPS Forecast

EPS202620272028
High0.37
Avg0.37
Low0.37

EPS Growth

EPS Growth202620272028
High
22.1%
Avg
22.1%
Low
22.1%